The ADDF Releases the 2018 Alzheimer's Clinical Trials Report
Read It
New Initiative to Fund the Development of Digital Alzheimer's Biomarkers
Learn More
A Recent Study Points to the Need for Broad Accessibility to PET Imaging
Read More
ADDF Statement on Biogen and Eisai Discontinuing Trials of Aducanumab
The BEACON Study Explores Treating Alzheimer's by Targeting Inflammation
Accelerate the Discovery of Drugs to Prevent and Treat Alzheimer's
About Us
CognitiveVitality.org:empowering you to protect your aging brain
Connecting researchers with CROs and drug discovery expertise
May 2
T.J. Oshie & Dr. Michela Gallagher Honored at Great Ladies Benefit
Apr 15
Second Annual Memories Matter Benefit Raises Over $1M
May 30
Thirteenth Annual Connoisseur’s Dinner
Jul 12
Program to Accelerate Clinical Trials
Neuroimaging and CSF Biomarker Development
Drug Discovery
Prevention Beyond the Pipeline
Accelerating Drug Discovery for FTD
